Pricing Log in Create free account

20/20 Biolabs Inc. (AIDX) vs Bluejay Diagnostics, Inc. (BJDX)

20/20 Biolabs Inc. and Bluejay Diagnostics, Inc. are both Medical Devices companies. 20/20 Biolabs Inc. and Bluejay Diagnostics, Inc. are of similar size ($2.5M and $2.5M). Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −298.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Bluejay Diagnostics, Inc. leads on 9 and 20/20 Biolabs Inc. on 3.

Valuation

Metric AIDX BJDX Medical Devices median
P/E n/m n/m 24.94
P/S 0.99 n/m 2.66
P/B 1.33 0.52 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA 0.39 n/m 11.42
EV/Sales (0.67) n/m 2.76
Earnings yield (436.45%) (368.94%) (12.66%)
Free cash flow yield (201.49%) (127.64%) (7.18%)

Profitability

Metric AIDX BJDX Medical Devices median
Gross margin 32.06% 0.00% 57.76%
Operating margin (198.15%) 0.00% (14.84%)
Net margin (298.16%) 0.00% (14.45%)
Free cash flow margin (200.12%) 0.00% (5.70%)
Return on equity 0.00% (98.89%) (10.56%)
Return on assets (211.61%) (81.07%) (17.26%)
Return on invested capital 0.00% 0.00% (5.22%)

Growth

Metric AIDX BJDX Medical Devices median
Revenue growth (TTM) — — 10.41%
EPS growth (last fiscal year) 34.28% 96.66% 28.17%
Revenue growth, 5-year CAGR — — 15.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AIDX BJDX Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 1.99 4.64 2.67
Net debt to EBITDA 0.11 0.76 0.54

Dividend

Metric AIDX BJDX Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric AIDX BJDX Medical Devices median
Market cap 2.50m 2.45m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack